Early multifocal electroretinography findings after intravitreal Conbercept in the treatment of wet age-related macular degeneration
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

Medical Scientific Research Foundation of Guangdong Province(No.A2016550)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    AIM: To evaluate the early changes of retinal function in patients with wet age-related macular degeneration(ARMD)after intravitreal Conbercept treatment by multifocal electroretinography(mfERG).

    METHODS: Wet ARMD patients diagnosed by fundus fluorescein angiography and received intravitreal injection of Conbercept(0.05mL/0.5mg)were included. Best corrected visual acuity(BCVA), incubation of N1, P1 and amplitude of P1 in mfERG test were recorded before and 1mo after treatment.

    RESULTS: Twenty patients(20 eyes)were enrolled in total. The mean BCVA was 0.80±0.48 LogMAR at baseline and improved to 0.65±0.50 LogMAR after treatment(P<0.001). Mean P1 amplitude density of the mfERG Ring 1 increased from 39.59±16.60nV/deg2 to 53.81±20.41nV/deg2(P=0.006). The change in visual acuity was positively correlated with the change in P1 amplitude density of Ring 1(r=-0.776, P<0.001).

    CONCLUSION: Intravitreal conbercept injection can improve the central retinal function of wet ARMD patients in the short term.

    Reference
    Related
    Cited by
Get Citation

Ding-Guo Huang, Jian-Long Zheng, Guo-Qiao Lin, et al. Early multifocal electroretinography findings after intravitreal Conbercept in the treatment of wet age-related macular degeneration. Guoji Yanke Zazhi( Int Eye Sci) 2018;18(9):1692-1695

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:February 02,2018
  • Revised:July 23,2018
  • Adopted:
  • Online: August 17,2018
  • Published: